Pancreatic Cancer

The Latest Research in Biliary Tract Cancers Presented at ASCO GI 2021

ASCO Highlights, Biliary Tract Cancer, Cholangiocarcinoma, Pancreatic Cancer

March 2021, Vol 2, No 1 — April 13, 2021

At the CCA Summit held during the 2021 ASCO Gastrointestinal (GI) Cancers Symposium, Rachna T. Shroff, MD, MS, Chief, Section of GI Medical Oncology, University of Arizona Cancer Center, Tucson, discussed 15 clinical trials that were presented at the ASCO GI Cancers Symposium on cholangiocarcinoma (CCA) and hepatobiliary diseases. She highlighted key advances related to chemotherapy, targeted therapies, and biomarkers in the management of biliary tract cancers, including CCA.

Institutional Review Data Indicate That Actionable Genetic Testing and Personalized Medicine in Hepatobiliary and Pancreatic Cancers Is Rarely Applied

Cholangiocarcinoma, Pancreatic Cancer

2020 Year in Review: Cholangiocarcinoma — December 19, 2020

Real-world data indicate that genetic testing and personalized medicine is rarely applied in the community setting for patients with hepatobiliary and pancreatic cancers.

Pancreatic Cancer

Subscribe Today!

I'd like to receive:

Stay In The Know